These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Testosterone deficiency, supplementation, and prostate cancer: maintaining a balanced perspective. Trost LW; Hellstrom WJ J Sex Med; 2013 Dec; 10(12):2879-81. PubMed ID: 24299509 [No Abstract] [Full Text] [Related]
6. Testosterone deficiency in older men: a problem worth treating. McHenry Martin C Consult Pharm; 2012 Mar; 27(3):152-63. PubMed ID: 22421515 [TBL] [Abstract][Full Text] [Related]
7. Hormone substitution in male hypogonadism. Zitzmann M; Nieschlag E Mol Cell Endocrinol; 2000 Mar; 161(1-2):73-88. PubMed ID: 10773395 [TBL] [Abstract][Full Text] [Related]
10. [Testosterone substitution with special regard to prostate cancer]. Beintker M; Behre H Urologe A; 2008 Dec; 47(12):1588-91. PubMed ID: 18931991 [TBL] [Abstract][Full Text] [Related]
11. The relation of testosterone levels with fatigue and apathy in Parkinson's disease. Kenangil G; Orken DN; Ur E; Forta H; Celik M Clin Neurol Neurosurg; 2009 Jun; 111(5):412-4. PubMed ID: 19131155 [TBL] [Abstract][Full Text] [Related]
18. Risks of testosterone-replacement therapy and recommendations for monitoring. Rhoden EL; Morgentaler A N Engl J Med; 2004 Jan; 350(5):482-92. PubMed ID: 14749457 [No Abstract] [Full Text] [Related]
19. Testosterone and the aging male: to treat or not to treat? Bain J Maturitas; 2010 May; 66(1):16-22. PubMed ID: 20153946 [TBL] [Abstract][Full Text] [Related]
20. Prostate magnetic resonance imaging findings in patients treated for testosterone deficiency while on active surveillance for low-risk prostate cancer. Hashimoto T; Rahul K; Takeda T; Benfante N; Mulhall JP; Hricak H; Eastham JA; Vargas HA Urol Oncol; 2016 Dec; 34(12):530.e9-530.e14. PubMed ID: 27665357 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]